James Yarmolinsky1, Bruce B Duncan2, Lloyd E Chambless3, Isabela M Bensenor4, Sandhi M Barreto5, Alessandra C Goulart4, Itamar S Santos4, Maria de Fátima Sander Diniz5, Maria Inês Schmidt6. 1. Postgraduate Program in Epidemiology, School of Medicine and Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; 2. Postgraduate Program in Epidemiology, School of Medicine and Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Epidemiology, and bbduncan@ufrgs.br. 3. Department of Biostatistics, University of North Carolina, Chapel Hill, NC; 4. Department of Clinical Medicine, Faculty of Medicine and Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo, São Paulo, Brazil; and. 5. Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil. 6. Postgraduate Program in Epidemiology, School of Medicine and Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil; Department of Epidemiology, and.
Abstract
BACKGROUND: Recent animal studies suggest that artificially sweetened beverage (ASB) consumption increases diabetes risk. OBJECTIVE: We examined the relation of ASB intake with newly diagnosed diabetes and measures of glucose homeostasis in a large Brazilian cohort of adults. METHODS: We used cross-sectional data from 12,884 participants from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). ASB use was assessed by questionnaire and newly diagnosed diabetes by a 2-h 75-g oral glucose tolerance test and/or glycated hemoglobin. Logistic and linear regression analyses were performed to examine the association of ASB consumption with diabetes and continuous measures of glucose homeostasis, respectively. RESULTS: Although ASB consumption was not associated with diabetes in logistic regression analyses after adjustment for body mass index (BMI; in kg/m(2)) overall, the association varied across BMI categories (P-interaction = 0.04). Among those with a BMI <25, we found a 15% increase in the adjusted odds of diabetes for each increase in the frequency of ASB consumption per day (P = 0.001); compared with nonusers, ASB users presented monotonic increases in the adjusted ORs (95% CIs) of diabetes with increased frequency of consumption: 1.03 (0.60, 1.77), 1.43 (0.93, 2.20), 1.62 (1.08, 2.44), and 2.51 (1.40, 4.50) for infrequent, 1-2, 3-4, and >4 times/d, respectively. In linear regression analyses, among normal-weight individuals, greater ASB consumption was also associated with increased fasting glucose concentrations (P = 0.01) and poorer β-cell function (P = 0.009). No such associations were seen for those with BMI ≥25. In fact, in overweight or obese participants, greater ASB consumption was significantly associated with improved indexes of insulin resistance and 2-h postload glucose. CONCLUSIONS: Normal-weight, but not excess-weight, individuals with greater ASB consumption presented diabetes more frequently and had higher fasting glucose and poorer β-cell function.
BACKGROUND: Recent animal studies suggest that artificially sweetened beverage (ASB) consumption increases diabetes risk. OBJECTIVE: We examined the relation of ASB intake with newly diagnosed diabetes and measures of glucose homeostasis in a large Brazilian cohort of adults. METHODS: We used cross-sectional data from 12,884 participants from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). ASB use was assessed by questionnaire and newly diagnosed diabetes by a 2-h 75-g oral glucose tolerance test and/or glycated hemoglobin. Logistic and linear regression analyses were performed to examine the association of ASB consumption with diabetes and continuous measures of glucose homeostasis, respectively. RESULTS: Although ASB consumption was not associated with diabetes in logistic regression analyses after adjustment for body mass index (BMI; in kg/m(2)) overall, the association varied across BMI categories (P-interaction = 0.04). Among those with a BMI <25, we found a 15% increase in the adjusted odds of diabetes for each increase in the frequency of ASB consumption per day (P = 0.001); compared with nonusers, ASB users presented monotonic increases in the adjusted ORs (95% CIs) of diabetes with increased frequency of consumption: 1.03 (0.60, 1.77), 1.43 (0.93, 2.20), 1.62 (1.08, 2.44), and 2.51 (1.40, 4.50) for infrequent, 1-2, 3-4, and >4 times/d, respectively. In linear regression analyses, among normal-weight individuals, greater ASB consumption was also associated with increased fasting glucose concentrations (P = 0.01) and poorer β-cell function (P = 0.009). No such associations were seen for those with BMI ≥25. In fact, in overweight or obeseparticipants, greater ASB consumption was significantly associated with improved indexes of insulin resistance and 2-h postload glucose. CONCLUSIONS: Normal-weight, but not excess-weight, individuals with greater ASB consumption presented diabetes more frequently and had higher fasting glucose and poorer β-cell function.
Authors: Jee-Young Moon; Simin Hua; Qibin Qi; Daniela Sotres-Alvarez; Josiemer Mattei; Sarah S Casagrande; Yasmin Mossavar-Rahmani; Anna María Siega-Riz; Linda C Gallo; Sylvia Wassertheil-Smoller; Robert C Kaplan; Leonor Corsino Journal: J Nutr Date: 2022-01-11 Impact factor: 4.798
Authors: Michele Drehmer; Andrew O Odegaard; Maria Inês Schmidt; Bruce B Duncan; Letícia de Oliveira Cardoso; Sheila M Alvim Matos; Maria Del Carmen B Molina; Sandhi M Barreto; Mark A Pereira Journal: Diabetol Metab Syndr Date: 2017-02-13 Impact factor: 3.320
Authors: Louise J C J den Biggelaar; Simone J S Sep; Andrea Mari; Ele Ferrannini; Martien C J M van Dongen; Nicole E G Wijckmans; Miranda T Schram; Carla J van der Kallen; Nicolaas Schaper; Ronald M A Henry; Marleen M van Greevenbroek; Coen D A Stehouwer; Simone J P M Eussen Journal: Eur J Nutr Date: 2019-09-05 Impact factor: 5.614